Member Info for daveboy19

I hope this is just me being pedantic, but noticed this at the end of the RNS (note phrasing change on date - why not just say June 2021 as previously stated) ?

Shield's lead product, Feraccru®/Accrufer®, has been approved for use in the United States, European Union, UK and Switzerland and has exclusive IP rights until the mid-2030s. The Group plans to launch Accrufer® in the US during 2021 through a highly experienced sales and marketing team.
They have just potentially added up to 6 months to the launch .... GLA.

Agreed, shandy - the US update by mid-May is crucial imo as this is the first deadline given under the 'new umbrella' so to speak. If it fails to materialize promptly, I will be concerned of old habits resurfacing. With luck, it will be the catalyst to instigate the recovery process.

Good stuff, shandy - only trouble is old damaged goods will be making the announcement in a fortnight or so! Hopefully anyways, unless he's just tugging our chains again as per the whole of last year.

I think his brother and uncle keep down ticking me on ADVFN ! - he's not the right person for the job, and that's a fact. They will hopefully carry the product through the US, but Tim will be nothing to do with that if they do. Can't down tick on here right Tim? Lol.

Somewhere in between ! And he's not telling it as it is, hence shandy's frustration. It therefore boils down to is he CEO material, pumper or not, and my feeling is he's a financial person and should not have been elevated to CEO. Those kind of statements he makes just back this up.

Yes, but a chart's value is diminished and rendered ineffective by sentiment - the ace of hearts in trumps !
They have hammered this point home with as lacklustre presentation I have seen (and I have seen Tim Watts present for STX).
Today's value for a cup and saucer formation here is her indoors bringing in a strong Nescafe.
I support the science and the drug, but they are really making this arduous now. Good luck all investors .

This shows the value of a chart !!

Lol, shandy - Mr Charisma will be in top gear as per!
Disappointed also that results are scheduled and come in minus the update every man and his dog are waiting for. Some over 2 years now, and they defer the update once again. If he doesn't deliver, he really should go. Last chance saloon for the guy. Would we still be in our jobs after all these shenanigans I wonder .... GLALTH as ever.

Also, Norgine poised for simultaneous hit on the Australian market - GLA.

Bang on with all of that. May launch would do wonders for sentiment imo.

Thanks for the update, shandy - much appreciated.
At least he took your call - fair play for that to him.

Have you heard Timothy speak before ... excitement is not the first word that springs to mind :¬)
However, if the content is good, or Brian gets involved, that could change. GLALTH.

Can't see it, as the market will be closed. Much as I'd love to as a LTH with dung on my head :¬)

I hope you're right, shandy, and they get someone in with a personality and some gumption!

These people always cover their own Harris's, come what may, and what a classic example here. Stunning incompetence being continually rewarded. Hard to look at alongside the big red dents in my portfolio!

Good luck to all here.

Never say never with Timmy at the helm.

He also knows they are adding 30/60 reps presumably ....

They already have a network of physicians in place, surveyed and ready to prescribe when allowed to (11,000 of 'em)!

Yep, impressive commitment.

Shield 'notes' - not 'pleased to announce'.
No comment from CEO saying how pleased he is that usually appear on most other RNS's.
What is it with these, FFS - soooo frustrating everything they do. Test the patience of a Saint!!
Hope Brian comes across well this afternoon. GLALTH.

Too true - the frustration of this company is palpable.
Years of nothing but broken promises and mistakes.
Get your questions ready for Timmy manana.